Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
Exelixis
Exelixis
Medical College of Wisconsin
Genentech, Inc.
Centre Georges Francois Leclerc
Fate Therapeutics
Fate Therapeutics
Celldex Therapeutics